About the Immunology and Cancer Session
Cancer remains a leading cause of mortality globally, and its yearly death toll of 8.2 million people is only anticipated to rise as the world's population ages. The presence of tumor-associated inflammatory cells in cancers poses a critical concern that is one of oncology's most pressing issues. Immunotherapy, which targets the immune system, has revolutionized cancer treatment in the previous decade. Many important questions about the causal relationship between chronic inflammation and carcinogenesis have been answered by immunological tests over the last two decades. Recent clinical and preclinical research has begun to reveal the wide range of systemic immune perturbations that occur during cancer development, and the critical role of peripheral immune cells in the anticancer immune response.
- Onco immunology
- Preclinical Models
- Inflammation
- Carcinogenesis
- Immune Checkpoint Inhibitors (Icis)
- Tumor Microenvironment (TME)
- Immune Therapies
- Peripheral Immune Cells and its Reorganization
Topics Covered in Immunology and Cancer
Cancer Immunoediting
Chronic Inflammation
Infiltrating Lymphocytes
Tumor-Associated Macrophages
Immune Checkpoints
Antigen Presentation
Related Scientific Sessions at CIOC 2027
Why Attend the Immunology and Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Immunology and Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Immunology and Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Immunology and Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Immunology and Cancer Conference 2027 — FAQs
What is the Immunology and Cancer track at CIOC 2027?
The Immunology and Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Immunology and Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Immunology and Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Immunology and Cancer are all welcome — whether presenting or attending.
Can I present my research in the Immunology and Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Immunology and Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Immunology and Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.